Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2011-02-11

Original market date: See footnote 1

2011-02-11

Product name:

UROCIT-K

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02353997

Product Monograph/Veterinary Labelling:

Date: 2010-08-04 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

MISSION PHARMACAL COMPANY
1000  10999 Ih 10 West
San Antonio
Texas
United States  78230-1355

Class: 

Human

Dosage form(s):

Tablet (Extended-Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

40:12.00   REPLACEMENT PREPARATIONS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A12BA02  POTASSIUM CITRATE

Active ingredient group (AIG) number:See footnote 5

0131342003

List of active ingredient(s)
Active ingredient(s) Strength
POTASSIUM CITRATE 1080 MG

Application information

Related information

Contact us

Version 3.9.0
Date modified: